Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 2/2020

Ausgabe 2/2020

Inhaltsverzeichnis ( 15 Artikel )

07.07.2020 | Review Article | Ausgabe 2/2020

Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells

R. Gajendra Reddy, Unis Ahmad Bhat, Sumana Chakravarty, Arvind Kumar

04.07.2020 | Original Article | Ausgabe 2/2020 Open Access

Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors

Erjian Wang, Steven G. DuBois, Cynthia Wetmore, Reza Khosravan

05.07.2020 | Original Article | Ausgabe 2/2020

A randomized, double-blind, parallel-group, single‑dose, pharmacokinetic bioequivalence study of INTP24 and bevacizumab in healthy adult men

Inderjeet Singh, Ronak Patel, Akash Patel, Vinu Jose

06.07.2020 | Original Article | Ausgabe 2/2020

Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study

Motoyasu Kan, Hiroshi Imaoka, Kazuo Watanabe, Mitsuhito Sasaki, Hideaki Takahashi, Yusuke Hashimoto, Izumi Ohno, Shuichi Mitsunaga, Kumiko Umemoto, Gen Kimura, Yuko Suzuki, Hiroki Eguchi, Toru Otsuru, Kyosuke Goda, Masafumi Ikeda

08.07.2020 | Original Article | Ausgabe 2/2020

Phase I safety and pharmacokinetic study of YM155, a potent selective survivin inhibitor, in combination with erlotinib in patients with EGFR TKI refractory advanced non-small cell lung cancer

Toshio Shimizu, Kazuto Nishio, Kazuko Sakai, Isamu Okamoto, Kunio Okamoto, Masayuki Takeda, Maiko Morishita, Kazuhiko Nakagawa

11.07.2020 | Original Article | Ausgabe 2/2020

Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer

Fang-Tao Wang, Hui Wang, Qi-Wei Wang, Mu-Su Pan, Xin-Ping Li, Wei Sun, Yue-Zu Fan

15.07.2020 | Original Article | Ausgabe 2/2020

Association of dry skin with intercellular lipid composition of stratum corneum after erlotinib administration

Tomonobu Uchino, Hiyori Fujino, Daichi Kamiya, Tomonori Suzuki, Yasunori Miyazaki, Kazuhiro Asada, Toshihiro Shirai, Hiroaki Yagi, Yuko Sano, Mutsumi Moriki, Hajime Mizuno, Kenichiro Todoroki, Midori Kimura, Yoshiyuki Kagawa

19.07.2020 | Original Article | Ausgabe 2/2020

Cytotoxic and biomechanical effects of clinical dosing schemes of paclitaxel on neurons and cancer cells

Chou-Ching K. Lin, Chih-Hsuan Yang, Ming-Shaung Ju

21.07.2020 | Original Article | Ausgabe 2/2020

Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells

Hui Zhang, Haoyu Xu, Ranran Zhang, Xinying Zhao, Ming Liang, Fenggui Wei

24.07.2020 | Original Article | Ausgabe 2/2020

A phase Ι study to evaluate the application of photocyanine using pharmacokinetic and pharmacodynamic analysis in patients with malignancy

Su Li, Bingtian Bi, Guangyu Luo, Jing Zhan, Rong Zhang, Jibin Li, Naisheng Chen, Jinling Huang, Jinping Xue, Guoliang Xu

24.07.2020 | Original Article | Ausgabe 2/2020

Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer

Yosuke Kito, Hironaga Satake, Hiroya Taniguchi, Takeshi Yamada, Yoshiki Horie, Taito Esaki, Tadamichi Denda, Hisateru Yasui, Naoki Izawa, Toshiki Masuishi, Toshikazu Moriwaki, Keita Mori, Kentaro Yamazaki

30.07.2020 | Original Article | Ausgabe 2/2020

A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401)

Hironori Samura, Eiji Oki, Hiroshi Okumura, Takefumi Yoshida, Seiichiro Kai, Kazuma Kobayashi, Tatsuya Kinjo, Shinichiro Mori, Tetsuo Tohyama, Kippei Ohgaki, Hirofumi Kawanaka, Akitaka Makiyama, Norio Ureshino, Masahito Kotaka, Takayuki Shimose, Koji Ando, Hiroshi Saeki, Hideo Baba, Yoshihiko Maehara, Masaki Mori

02.08.2020 | Original Article | Ausgabe 2/2020

HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer

Jiahong Jiang, Shaohai Wang, Zehua Wang, Jing Cai, Lingling Han, Lisha Xie, Qing Han, Wenwen Wang, Yifan Zhang, Xiaoqi He, Chun Yang

03.08.2020 | Original Article | Ausgabe 2/2020

Excretion balance and pharmacokinetics following a single oral dose of [14C]-fedratinib in healthy subjects

Ken Ogasawara, Christine Xu, Vanaja Kanamaluru, Nicholas Siebers, Sekhar Surapaneni, Laurence Ridoux, Maria Palmisano, Gopal Krishna

03.08.2020 | Original Article | Ausgabe 2/2020

ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy

Hisanaga Nomura, Daiki Tsuji, Ken Demachi, Nobuo Mochizuki, Haruki Matsuzawa, Tomonori Yano, Hiroyuki Daiko, Satoshi Fujii, Takashi Kojima, Kunihiko Itoh, Toshikatsu Kawasaki

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise